Porewater_Steinsberger_2017.xlsx

Porewater and sediment data used to compile the results presented in Steinsberger et al. (2017)

Predictors of newly-diagnosed atrial fibrillation in cohort A*.

<p>Univariate logistic regression, ^#p<0.05.</p

Baseline characteristics of patient cohorts as described in figure 1.

<p>(INS  =  insular stroke, NDAF  =  newly diagnosed atrial fibrillation, NIHSS  =  National Institute of Health Stroke Scale, IQR  =  Interquartile Range, CAD  =  coronary artery disease).*p<0.05.</p

Timecourse of plasma MR-proANP levels.

<p>Plasma lnMR-proANP levels are plotted on the ordinate, lnMR-proANP levels were significantly different between patient groups throughout the monitored period (day 0 denotes the day of admission; ** p<0.01, *** p<0.001, one-way ANOVA with Bonferroni’s multiple comparisons post-hoc test). The abscissa denotes the time points of plasma MR-proANP levels during the hospitalization period in patients with no newly-diagnosed atrial fibrillation (no NDAF, blue boxes) and those with newly-diagnosed atrial fibrillation (NDAF, red boxes). Horizontal bars indicate group means with error bars denoting 95% CI.</p

Comparison of the area under the receiver operating characteristic curve of each model in cohort A.

<p>*p<0.05<b>.</b></p

Cortisol values basal (black) and after stimulation with 1 μg corticotropin (grey) and corresponding basal ACTH concentrations for all patients at six clinical visits

<p><b>Copyright information:</b></p><p>Taken from "Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease"</p><p>http://www.biomedcentral.com/1471-2466/8/1</p><p>BMC Pulmonary Medicine 2008;8():1-1.</p><p>Published online 26 Jan 2008</p><p>PMCID:PMC2246097.</p><p></p

ROC curve analysis to predict adrenal insufficiency for basal cortisol, ACTH, the cortisol/ACTH ratio and the clinical score

<p><b>Copyright information:</b></p><p>Taken from "Effect of a 14-day course of systemic corticosteroids on the hypothalamic-pituitary-adrenal-axis in patients with acute exacerbation of chronic obstructive pulmonary disease"</p><p>http://www.biomedcentral.com/1471-2466/8/1</p><p>BMC Pulmonary Medicine 2008;8():1-1.</p><p>Published online 26 Jan 2008</p><p>PMCID:PMC2246097.</p><p></p

Procedural complications of the external validation cohort according to all-cause mortality and upper quartile of MR-proADM.

<p>Procedural complications of the external validation cohort according to all-cause mortality and upper quartile of MR-proADM.</p

Clinical model enhancement by addition of MR-proADM.

<p><b>Risk assessment plot for the reference (EuroSCORE II, dashed lines) and biomarker-enhanced (solid line) model for 1-year mortality;</b> 1-specificity versus calculated risk for those with the event and sensitivity versus calculated risk for those without events are shown.</p

Baseline characteristics of the external validation population and according to all-cause mortality and upper quartile of MR-proADM.

<p>¹GFR<60ml/min.</p><p>²Long-term use of bronchodilatators or steroids.</p><p>Abbreviations: GFR = glomerular filtration rate, SAVR = surgical aortic valve replacement, CABG = coronary artery bypass grafting, MI = myocardial infarction, NYHA = New York Heart Association, COPD = chronic obstructive pulmonary disease, BMI = body mass index, CAD = coronary artery disease.</p><p>Baseline characteristics of the external validation population and according to all-cause mortality and upper quartile of MR-proADM.</p